These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 11199955)
1. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. Wong YW; Yeh C; Thyrum PT J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955 [TBL] [Abstract][Full Text] [Related]
2. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders. Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267 [TBL] [Abstract][Full Text] [Related]
3. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256 [TBL] [Abstract][Full Text] [Related]
4. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine. Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA; J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients. Ribolsi M; Magni V; Rubino IA Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318 [TBL] [Abstract][Full Text] [Related]
7. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Figueroa C; Brecher M; Hamer-Maansson JE; Winter H Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162 [TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of acute response with quetiapine in psychotic mood disorders. Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103 [TBL] [Abstract][Full Text] [Related]
10. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876 [TBL] [Abstract][Full Text] [Related]
11. Quetiapine alone and added to a mood stabilizer for serious mood disorders. Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770 [TBL] [Abstract][Full Text] [Related]
13. Quetiapine: a review of its safety in the management of schizophrenia. Dev V; Raniwalla J Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217 [TBL] [Abstract][Full Text] [Related]
14. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol. Küfferle B; Tauscher J; Asenbaum S; Vesely C; Podreka I; Brücke T; Kasper S Psychopharmacology (Berl); 1997 Oct; 133(4):323-8. PubMed ID: 9372530 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with quetiapine in elderly patients with psychotic disorders. Madhusoodanan S; Brenner R; Alcantra A J Geriatr Psychiatry Neurol; 2000; 13(1):28-32. PubMed ID: 10753004 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders. Jaskiw GE; Thyrum PT; Fuller MA; Arvanitis LA; Yeh C Clin Pharmacokinet; 2004; 43(14):1025-35. PubMed ID: 15530131 [TBL] [Abstract][Full Text] [Related]
17. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study. Chengappa KN; Parepally H; Brar JS; Mullen J; Shilling A; Goldstein JM Can J Psychiatry; 2003 Apr; 48(3):187-94. PubMed ID: 12728743 [TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment. Thyrum PT; Wong YW; Yeh C Prog Neuropsychopharmacol Biol Psychiatry; 2000 May; 24(4):521-33. PubMed ID: 10958148 [TBL] [Abstract][Full Text] [Related]
19. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. Dando TM; Keating GM Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876 [TBL] [Abstract][Full Text] [Related]
20. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Copolov DL; Link CG; Kowalcyk B Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]